Clinical Centres (ward/participating physicians, APHP Cochin ,
, APHP Pitié-Salpétrière
, APHP Pitié-Salpétrière
, Virologie: C. Tamalet)
, Virologie: C. Le Pendeven
, Toulouse (Maladies Infectieuses et Tropicales: B. Marchou; Hépato-gastro-entérologie: L. Alric, K. Barange, S. Metivier; Anatomo-pathologie, Virologie: F. Larroquette
, Infectiologie: A. Naqvi, V. Rio; Anatomo-pathologie, Virologie: C. Partouche)
, Médecine Interne-Unité VIH: O. Bouchaud; Anatomo-pathologie: M. Ziol
,
, Virologie: F. Nicot
, Virologie: G. Alexandre
,
, Maladies Infectieuses et Tropicales
, Virologie: C. Viala)
, Virologie: C. Pallier; Maladies Infectieuses: D. Vittecoq
, Virologie: V. Avettand-Fenoel, A. Mélard
, Bordeaux (Maladies Infectieuses et Tropicales: D. Neau
, Virologie: P. Trimoulet, S. Reigadas
, Médecine Interne et Maladies Infectieuses: Médecine Interne et Maladies Infectieuses: P. Morlat
, Virologie: P. Trimoulet, S. Reigadas
, Virologie: E. Farfour)
, Virologie : C. Deback)
, Nantes (Maladies Infectieuses et Tropicales: E. Billaud
,
, Lyon (Maladies Infectieuses et Tropicales: P
,
, Simonet-Lann, D. Croisier-Bertin
, Perpignan (Maladies infectieuses et tropicales: H. Aumaître)
Reims (Médecine interne, maladies infectieuses et immunologie clinique ,
, Virologie: P Gantner et S Fafi-Kremer)
Data collection ,
URL : https://hal.archives-ouvertes.fr/hal-01678034
, Management
We especially thank all physicians and nurses who are involved in the follow-up of the cohort and all patients who took part in this study ,
Pathophysiology of hepatitis C virus infection and related liver disease, Trends Microbiol, vol.12, pp.96-102, 2004. ,
DOI : 10.1016/j.tim.2003.12.005
HCV-related hepatocellular carcinoma: From chronic inflammation to cancer, Clin. Immunol, vol.134, pp.237-250, 2010. ,
DOI : 10.1016/j.clim.2009.10.007
Canadian Co-infection Cohort Study (CTN 222). A prognostic model for development of significant liver fibrosis in HIV-hepatitis C co-infection, PLoS ONE, vol.12, 2017. ,
Fibrosis and disease progression in hepatitis C, Hepatology, vol.36, pp.47-56, 2002. ,
DOI : 10.1053/jhep.2002.36993
Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C, J. Hepatol, vol.34, pp.730-739, 2001. ,
Alcoholic Liver Disease: High Risk or Low Risk for Developing Hepatocellular Carcinoma? Clin. Liver Dis, vol.20, pp.563-580, 2016. ,
Coffee Consumption Decreases Risks for Hepatic Fibrosis and Cirrhosis: A Meta-Analysis, PLoS ONE, vol.10, 2015. ,
DOI : 10.1371/journal.pone.0142457
URL : https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0142457&type=printable
Coffee and herbal tea consumption is associated with lower liver stiffness in the general population: The Rotterdam study, J. Hepatol, vol.67, pp.339-348, 2017. ,
Caffeine (1, 3, 7-trimethylxanthine) in Foods: A Comprehensive Review on Consumption, Functionality, Safety, and Regulatory Matters, J. Food Sci, vol.75, pp.77-87, 2010. ,
Coffee components and cardiovascular risk: Beneficial and detrimental effects, Int. J. Food Sci. Nutr, vol.65, pp.925-936, 2014. ,
Caffeine, and Health Outcomes: An Umbrella Review, Annu. Rev. Nutr, vol.37, pp.131-156, 2017. ,
Coffee consumption and risk of all-cause, cardiovascular, and cancer mortality in smokers and non-smokers: A dose-response meta-analysis, Eur. J. Epidemiol, vol.31, pp.1191-1205, 2016. ,
Coffee and cancer risk: A summary overview, Eur. J. Cancer Prev, vol.26, pp.424-432, 2017. ,
Long-term coffee consumption and risk of cardiovascular disease: A systematic review and a dose-response meta-analysis of prospective cohort studies, Circulation, vol.129, pp.643-659, 2014. ,
ANRS CO13 HEPAVIH Study Group. Association between elevated coffee consumption and daily chocolate intake with normal liver enzymes in HIV-HCV infected individuals: Results from the ANRS CO13 HEPAVIH cohort study, J. Hepatol, vol.60, pp.46-53, 2014. ,
Coffee consumption is associated with lower serum aminotransferases in the general Korean population and in those at high risk for hepatic disease, Asia Pac. J. Clin. Nutr, vol.25, pp.767-775, 2016. ,
Coffee and liver health, J. Clin. Gastroenterol, vol.48, 2014. ,
Interaction of alcohol intake and cofactors on the risk of cirrhosis, Liver Int, vol.30, pp.867-870, 2010. ,
Coffee Intake Is Associated with Lower Rates of Liver Disease Progression in Chronic Hepatitis C, Hepatology, vol.50, pp.1360-1369, 2009. ,
Coffee consumption and reduced self-reported side effects in HIV-HCV co-infected patients during PEG-IFN and ribavirin treatment: Results from ANRS CO13 HEPAVIH, J. Hepatol, vol.56, pp.745-747, 2012. ,
Caffeine attenuates liver fibrosis via defective adhesion of hepatic stellate cells in cirrhotic model, J. Gastroenterol. Hepatol, vol.28, pp.1877-1884, 2013. ,
Coffee consumption and risk of hepatocellular carcinoma: A meta-analysis of eleven epidemiological studies, OncoTargets Ther, vol.9, pp.4369-4375, 2016. ,
The French national prospective cohort of patients co-infected with HIV and HCV, ANRS CO13 HEPAVIH): Early findings, vol.10, p.303, 2006. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01070193
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection, Hepatology, vol.43, pp.1317-1325, 2006. ,
Protective effect of coffee consumption on all-cause mortality of French HIV-HCV co-infected patients, J. Hepatol, 2017. ,
Liver fibrosis progression despite HCV cure with antiviral therapy in HIV-HCV-coinfected patients, Antivir. Ther, vol.20, pp.329-334, 2015. ,
Coffee and green tea consumption is associated with upper aerodigestive tract cancer in Japan, Int. J. Cancer, vol.135, pp.391-400, 2014. ,
Coffee consumption and mortality in three Eastern European countries: Results from the HAPIEE (Health, Alcohol and Psychosocial factors in Eastern Europe) study. Public Health Nutr, vol.20, pp.82-91, 2017. ,
Systematic review with meta-analysis: Coffee consumption and the risk of cirrhosis, Aliment. Pharmacol. Ther, vol.43, pp.562-574, 2016. ,
Coffee Drinking and Alcoholic and Nonalcoholic Fatty Liver Diseases and Viral Hepatitis in the Multiethnic Cohort, Clin. Gastroenterol. Hepatol, vol.15, pp.1305-1307, 2017. ,
Effects of caffeine consumption in patients with chronic hepatitis C: A systematic review and meta-analysis, Clin. Res. Hepatol. Gastroenterol, vol.41, pp.46-55, 2017. ,
Coffee Consumption and Risk of Liver Cancer: A Meta-Analysis, Gastroenterology, vol.132, pp.1740-1745, 2007. ,
The Impact of Coffee on Health, vol.83, pp.1256-1263, 2017. ,
Chlorogenic acid reduces liver inflammation and fibrosis through inhibition of toll-like receptor 4 signaling pathway, Toxicology, vol.303, pp.107-114, 2013. ,
Relationship between alcohol use categories and noninvasive markers of advanced hepatic fibrosis in HIV-infected, chronic hepatitis C virus-infected, and uninfected patients, Clin. Infect. Dis, vol.58, pp.1449-1458, 2014. ,
High levels of alcohol consumption increase the risk of advanced hepatic fibrosis in HIV/hepatitis C virus-coinfected patients: A sex-based analysis using transient elastography at enrollment in the HEPAVIH ANRS CO13 cohort, Clin. Infect. Dis, vol.59, pp.1190-1192, 2014. ,
URL : https://hal.archives-ouvertes.fr/inserm-01997182
Molecular mechanism of hepatic injury in coinfection with hepatitis C virus and HIV, Clin. Infect. Dis, pp.32-37, 2005. ,
Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-?)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection, Clin. Res. Hepatol. Gastroenterol, vol.41, pp.644-655, 2017. ,
IL-1? Production through the NLRP3 Inflammasome by Hepatic Macrophages Links Hepatitis C Virus Infection with Liver Inflammation and Disease, PLoS Pathog, vol.9, 2013. ,
Hepatic inflammation and progressive liver fibrosis in chronic liver disease, World J. Gastroenterol, vol.20, pp.2515-2532, 2014. ,
DOI : 10.3748/wjg.v20.i10.2515
URL : https://doi.org/10.3748/wjg.v20.i10.2515
Assessing the antioxidant activity of melanoidins from coffee brews by different antioxidant methods, J. Agric. Food Chem, vol.53, pp.7832-7836, 2005. ,
High coffee intake is associated with lower grade nonalcoholic fatty liver disease: The role of peripheral antioxidant activity, Ann. Hepatol, vol.11, pp.350-355, 2012. ,
A Supplement That May Block. The Toxic Effects of Alcohol, 2017. ,
Changes in liver fibrosis in HIV/HCV-coinfected patients following different outcomes with peginterferon plus ribavirin therapy, J. Viral Hepat, vol.21, pp.475-479, 2014. ,
Liver fibrosis progression in HIV-HCV-coinfected patients treated with distinct antiretroviral drugs and impact of pegylated interferon/ribavirin therapy, Antiviral Ther, vol.19, pp.287-292, 2014. ,
Regression of liver stiffness after sustained hepatitis C virus (HCV) virological responses among HIV/HCV-coinfected patients, AIDS, vol.29, pp.1821-1830, 2015. ,
Serum fibrosis marker levels decrease after successful antiviral treatment in chronic hepatitis C patients with advanced fibrosis, Clin. Gastroenterol. Hepatol, vol.7, pp.219-226, 2009. ,
Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus, Hepatology, vol.50, pp.407-413, 2009. ,
DOI : 10.1002/hep.23020
Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group, Hepatology, vol.30, pp.1054-1058, 1999. ,
Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: A meta-analysis, Clin. Infect. Dis, vol.33, pp.562-569, 2001. ,
Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy, J. Hepatol, vol.44, pp.47-55, 2006. ,
French National Agency for Research on AIDS; et al. Progression of fibrosis in HIV and hepatitis C virus-coinfected patients treated with interferon plus ribavirin-based therapy: Analysis of risk factors, Clin. Infect. Dis, vol.46, pp.768-774, 2008. ,
Didanosine (ddI) associates with increased liver fibrosis in adult HIV-HCV coinfected patients, J. Viral Hepat, vol.19, pp.685-693, 2012. ,
Concurrent Obesity, Diabetes, and Steatosis Increase Risk of Advanced Fibrosis among HCV Patients: A Systematic Review, Dig. Dis. Sci, vol.60, pp.2813-2824, 2015. ,
Insulin resistance: A major factor associated with significant liver fibrosis in Egyptian patients with genotype 4 chronic hepatitis C, Eur. J. Gastroenterol. Hepatol, vol.25, pp.421-427, 2013. ,
Factors Associated with Hepatic Fibrosis in Patients with Chronic Hepatitis C: A Retrospective Study of a Large Cohort of U.S. Patients, J. Clin. Gastroenterol, vol.43, pp.758-764, 2009. ,
Obesity and non-alcoholic fatty liver disease in chronic hepatitis C, J. Clin. Gastroenterol, vol.38, pp.705-709, 2004. ,
Coffee, including caffeinated and decaffeinated coffee, and the risk of hepatocellular carcinoma: A systematic review and dose-response meta-analysis, BMJ Open, vol.7, 2017. ,
Coffee Consumption and Risk of Biliary Tract Cancers and Liver Cancer: A Dose-Response Meta-Analysis of Prospective Cohort Studies, Nutrients, vol.9, p.950, 2017. ,